https://pharmadog.xyz/news/615714 pharmadog en 2026-10-30T20:32:08.000Z FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis https://pharmadog.xyz/news/614871 pharmadog en 2026-10-30T16:16:51.000Z Sanofi plans to pursue higher European drug prices rather than delay product launches under Trump policy https://pharmadog.xyz/news/615082 pharmadog en 2026-10-30T16:16:00.000Z Vitality Works recalls 365 Whole Foods Ashwagandha capsules over possible Salmonella contamination https://pharmadog.xyz/news/614935 pharmadog en 2026-10-30T16:00:00.000Z Moderna and Merck’s individualized cancer vaccine shows promising melanoma results but shares tumble after ESMO presentation https://pharmadog.xyz/news/614703 pharmadog en 2026-10-30T15:47:13.000Z Gilead places CAR-T program on partial hold after ICANS cases; Agios delays PDUFA submission https://pharmadog.xyz/news/614728 pharmadog en 2026-10-30T15:42:22.000Z AbbVie beats Q3 expectations, lifts full-year EPS outlook as immunology and neuroscience drive growth https://pharmadog.xyz/news/614704 pharmadog en 2026-10-30T15:36:16.000Z AstraZeneca hints restructuring may trim R&D budget and move trials to emerging markets https://pharmadog.xyz/news/134233 pharmadog en 2026-10-30T15:30:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/614729 pharmadog en 2026-10-30T15:23:41.000Z AstraZeneca launches $1.5 billion cost-saving plan to fund growth, says no layoffs expected https://pharmadog.xyz/news/614730 pharmadog en 2026-10-30T15:07:04.000Z Regeneron posts $5.1 billion Q3 revenue, beating forecasts and highlighting strong sales of Dupixent, Eylea HD and Libtayo https://pharmadog.xyz/news/614731 pharmadog en 2026-10-30T15:03:13.000Z Sanofi eyes late-stage and commercial acquisitions to counter upcoming Dupixent revenue drop https://pharmadog.xyz/news/614579 pharmadog en 2026-10-30T14:45:50.000Z Vir Biotechnology appoints David Liu as chief medical officer https://pharmadog.xyz/news/614580 pharmadog en 2026-10-30T14:07:14.000Z Election stress linked to higher risk of arrhythmias and heart attacks, study finds https://pharmadog.xyz/news/614411 pharmadog en 2026-10-30T13:33:55.000Z Podcast examines Merck and Moderna’s mRNA cancer vaccine data presented at ESMO https://pharmadog.xyz/news/614412 pharmadog en 2026-10-30T13:22:49.000Z STAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more https://pharmadog.xyz/news/614391 pharmadog en 2026-10-30T13:13:04.000Z Acumen scraps sole asset after Alzheimer’s fail, plunging stock 80% https://pharmadog.xyz/news/614413 pharmadog en 2026-10-30T13:12:49.000Z Lancet series highlights men’s health paradox and rising urgent-care costs https://pharmadog.xyz/news/614367 pharmadog en 2026-10-30T13:00:09.000Z Anthropic appoints former Genentech scientist Nathan Frey to lead drug discovery after acquiring Coefficient Bio https://pharmadog.xyz/news/614223 pharmadog en 2026-10-30T12:46:26.000Z Alnylam shares tumble 25% as analysts flag uncertainties in its transthyretin franchise https://pharmadog.xyz/news/614095 pharmadog en 2026-10-30T11:50:00.000Z Lilly beats forecasts and raises outlook as Novartis steadies and GSK faces investor pressure https://pharmadog.xyz/news/614031 pharmadog en 2026-10-30T11:12:36.000Z Sanofi says no major restructuring despite upcoming Dupixent patent expiration https://pharmadog.xyz/news/614032 pharmadog en 2026-10-30T11:00:55.000Z Former Be Bio chief Joanne Smith-Farrell appointed CEO of Orbis Medicines as Enanta CEO Jay Luly announces retirement https://pharmadog.xyz/news/613888 pharmadog en 2026-10-30T10:32:00.000Z Setara Biosciences raises $90 million Series A to advance Jazz-spun rare disease programs https://pharmadog.xyz/news/613887 pharmadog en 2026-10-30T10:32:00.000Z Early-stage data show promise for targeting Wnt/β-catenin pathway across cancers https://pharmadog.xyz/news/613863 pharmadog en 2026-10-30T10:30:35.000Z Setara Biosciences raises $90 million to advance rare-disease pipeline after Actio spin-out https://pharmadog.xyz/news/614264 pharmadog en 2026-10-30T10:30:00.000Z Setara Biosciences launches with $90 million to pursue Charcot-Marie-Tooth and other rare-disease therapies https://pharmadog.xyz/news/613864 pharmadog en 2026-10-30T10:00:25.000Z AI-Driven Biotech Startups May Soon Operate With Zero or One Employee, Says Endpoints News Live Discussion https://pharmadog.xyz/news/613695 pharmadog en 2026-10-30T09:49:35.000Z AstraZeneca launches $1.5 billion annual cost-saving plan to offset late-stage trial setbacks https://pharmadog.xyz/news/614342 pharmadog en 2026-10-30T09:33:00.000Z Third Rock partner’s brain cancer diagnosis highlights personal impact of biotech drug development https://pharmadog.xyz/news/613466 pharmadog en 2026-10-30T08:30:00.000Z Congress must restore independence of scientific advisory panels after controversial firings https://pharmadog.xyz/news/613465 pharmadog en 2026-10-30T08:30:00.000Z STAT reporters outline how upcoming midterms could reshape US vaccine, drug policy and the MAHA movement https://pharmadog.xyz/news/613467 pharmadog en 2026-10-30T08:30:00.000Z Patient billed $1,756 after routine urgent-care visit for UTI at Texas clinic https://pharmadog.xyz/news/613463 pharmadog en 2026-10-30T08:30:00.000Z 1834 measles letter highlights historic roots of today's anti-vaccine sentiment https://pharmadog.xyz/news/613464 pharmadog en 2026-10-30T08:30:00.000Z FDA and CMS work to prevent regulatory clash as states move to test clinical AI https://pharmadog.xyz/news/614957 pharmadog en 2026-10-30T07:43:00.000Z Bracco to invest $230M in new US contrast media plant, creating 200 jobs https://pharmadog.xyz/news/613083 pharmadog en 2026-10-30T06:11:31.000Z Aspen Neuroscience and Bambusa raise $310M combined in IPOs https://pharmadog.xyz/news/613562 pharmadog en 2026-10-30T05:04:00.000Z AstraZeneca drops two early-phase prostate cancer programs https://pharmadog.xyz/news/613394 pharmadog en 2026-10-30T04:02:00.000Z Bambusa Therapeutics exceeds IPO target raising $169 million, while Aspen Neuroscience falls short with $141 million https://pharmadog.xyz/news/615566 pharmadog en 2026-10-30T04:00:00.000Z Nova Biomedical issues safety instructions for StatStrip Glucose Hospital Meter Gen 2.0 https://pharmadog.xyz/news/615567 pharmadog en 2026-10-30T04:00:00.000Z Instrumentation Laboratories recalls several lots of HemosIL AcuStar HIT-IgG(PF4-H) assay due to false-negative risk https://pharmadog.xyz/news/613226 pharmadog en 2026-10-30T03:55:00.000Z Roche launches VENTANA BAP1 test to improve mesothelioma diagnosis https://pharmadog.xyz/news/613227 pharmadog en 2026-10-30T03:28:00.000Z Sanofi eyes 'moonshot' drug acquisitions to offset upcoming Dupixent patent loss https://pharmadog.xyz/news/613228 pharmadog en 2026-10-30T03:19:00.000Z Molecular Partners to cut up to 44% of staff as it shifts focus to radiotherapy pipeline https://pharmadog.xyz/news/612407 pharmadog en 2026-10-30T02:38:00.000Z Aspen Neuroscience raises $140M IPO to advance Parkinson’s cell therapy https://pharmadog.xyz/news/611686 pharmadog en 2026-10-29T21:26:00.000Z SLR Food Distribution recalls Wise Wife ground cinnamon over possible lead contamination https://pharmadog.xyz/news/611291 pharmadog en 2026-10-29T20:30:00.000Z Labor Dept finalizes PBM disclosure rule to boost transparency for self-insured employers https://pharmadog.xyz/news/611059 pharmadog en 2026-10-29T19:31:38.000Z Eli Lilly leans on cash-pay model to grow obesity drug sales in US and overseas https://pharmadog.xyz/news/610827 pharmadog en 2026-10-29T18:57:37.000Z Federal judge blocks narrow Medicaid frailty definition, expanding work-requirement exemptions https://pharmadog.xyz/news/614350 pharmadog en 2026-10-29T18:40:00.000Z Gilead places partial clinical hold on two KITE-753 CAR-T trials in diffuse large B-cell lymphoma https://pharmadog.xyz/news/610783 pharmadog en 2026-10-29T18:33:44.000Z Bristol Myers Squibb emphasizes pipeline strength and later-stage partnership focus amid patent cliff concerns https://pharmadog.xyz/news/610807 pharmadog en 2026-10-29T18:17:34.000Z Dren Bio raises $350 million to advance rare blood cancer antibody https://pharmadog.xyz/news/610615 pharmadog en 2026-10-29T18:00:02.000Z Merck R&D chief says company has outpaced rivals with its sac-TMT cancer platform https://pharmadog.xyz/news/610491 pharmadog en 2026-10-29T16:44:05.000Z Federal rule forces PBMs to disclose fees and rebates to employers https://pharmadog.xyz/news/610492 pharmadog en 2026-10-29T16:15:20.000Z STAT Health Tech newsletter previews EPIC probe, Teladoc surprise and AI payment challenges https://pharmadog.xyz/news/610471 pharmadog en 2026-10-29T16:06:04.000Z Eli Lilly lifts guidance by $10 billion as GLP‑1 sales outpace expectations https://pharmadog.xyz/news/610511 pharmadog en 2026-10-29T16:06:00.000Z Genmab shares jump as petosemtamab plus Keytruda halves death risk in head-neck cancer trial https://pharmadog.xyz/news/610472 pharmadog en 2026-10-29T16:05:48.000Z Merck projects continued investment and growth as Keytruda patent expires https://pharmadog.xyz/news/614174 pharmadog en 2026-10-29T15:53:00.000Z Eli Lilly consolidates US and international sales under new global markets unit as veteran exec retires https://pharmadog.xyz/news/610303 pharmadog en 2026-10-29T15:47:53.000Z BMS shelves Prothena-partnered neuro drug after Phase 1 review, but raises full-year revenue outlook on 7% Q3 sales growth https://pharmadog.xyz/news/610279 pharmadog en 2026-10-29T15:31:16.000Z UK secures £500m biopharma investment as Vertex commits over £300m to new Oxford R&D hub, while Teva plans New Jersey plant closure https://pharmadog.xyz/news/610280 pharmadog en 2026-10-29T15:08:22.000Z Ono Pharma’s endocannabinoid drug ONO-1110 fails five Phase 2 trials, prompting broader concerns https://pharmadog.xyz/news/610281 pharmadog en 2026-10-29T15:06:45.000Z Genmab shares climb after head-and-neck cancer data as Iovance and Coherus stocks fall https://pharmadog.xyz/news/610111 pharmadog en 2026-10-29T14:49:42.000Z Big tech and startups are building personal AI agents to analyze patients’ medical records https://pharmadog.xyz/news/610155 pharmadog en 2026-10-29T14:45:48.000Z RFK Jr. Addresses Iowa Rally Calling for Covid Vaccine Removal and Highlighting MAHA Movement https://pharmadog.xyz/news/610156 pharmadog en 2026-10-29T14:18:27.000Z Michigan Senate candidate El-Sayed rebuts RFK Jr. and highlights FDA's new enforcement discretion on peptide drugs https://pharmadog.xyz/news/609987 pharmadog en 2026-10-29T13:43:44.000Z HHS permits compounding of six experimental peptides despite FDA scientists' safety concerns https://pharmadog.xyz/news/609968 pharmadog en 2026-10-29T13:38:58.000Z Ono Pharma halts ONO-1110 development for depression and anxiety after five Phase 2 failures, continues pain studies https://pharmadog.xyz/news/609988 pharmadog en 2026-10-29T13:38:36.000Z Biostatistician Martin Kulldorff Criticizes NIH Gatekeepers Over Measles Claims https://pharmadog.xyz/news/609879 pharmadog en 2026-10-29T13:25:01.000Z Vertex kidney disease drug faces infection risk scrutiny ahead of FDA decision https://pharmadog.xyz/news/609835 pharmadog en 2026-10-29T13:00:32.000Z Anthropic outlines biopharma strategy ahead of potential record-size IPO https://pharmadog.xyz/news/609859 pharmadog en 2026-10-29T12:59:59.000Z Lilly can’t stop, won’t stop as revenue climbs 39% thanks to GLP-1 bestsellers https://pharmadog.xyz/news/609711 pharmadog en 2026-10-29T12:52:11.000Z HHS issues temporary policy permitting compounding pharmacies to produce certain peptide drugs https://pharmadog.xyz/news/610758 pharmadog en 2026-10-29T11:59:00.000Z Eli Lilly halts phase 2 Alzheimer's trial of mevidalen after missing internal targets https://pharmadog.xyz/news/609499 pharmadog en 2026-10-29T11:21:53.000Z Eli Lilly beats Q3 revenue forecasts, lifts full-year outlook https://pharmadog.xyz/news/609523 pharmadog en 2026-10-29T11:17:00.000Z HHS adopts enforcement discretion allowing compounding pharmacies to produce six unapproved peptides https://pharmadog.xyz/news/613838 pharmadog en 2026-10-29T11:16:00.000Z Setara Biosciences raises $90M Series A to advance neuroscience pipeline after Jazz's $820M Actio acquisition https://pharmadog.xyz/news/609500 pharmadog en 2026-10-29T11:00:08.000Z Dren Bio secures $350 million to advance blood-cancer therapy toward 2027 launch https://pharmadog.xyz/news/610254 pharmadog en 2026-10-29T10:55:00.000Z Merck says 2027 will focus on pipeline and new product launches despite recent trial wins https://pharmadog.xyz/news/609331 pharmadog en 2026-10-29T10:30:03.000Z Flagship Pioneering merges three portfolio companies to boost AI drug discovery https://pharmadog.xyz/news/609395 pharmadog en 2026-10-29T10:30:00.000Z Flagship Pioneering merges three biotech startups to launch AI-driven drugmaker Etcelera https://pharmadog.xyz/news/610087 pharmadog en 2026-10-29T10:14:00.000Z BioMarin signs up to $475 million licensing deal for new Fabry disease enzyme therapy https://pharmadog.xyz/news/609207 pharmadog en 2026-10-29T10:00:00.000Z New tumor atlas reveals why colorectal cancer is more aggressive in younger patients https://pharmadog.xyz/news/609187 pharmadog en 2026-10-29T09:48:00.000Z Australia emerges as a hub for early-stage clinical trials thanks to speed, clear regulations and tax incentives https://pharmadog.xyz/news/610086 pharmadog en 2026-10-29T09:04:00.000Z BMS drops $80 million neurodegeneration program after phase-1 results https://pharmadog.xyz/news/609041 pharmadog en 2026-10-29T08:30:00.000Z Voters demand action on soaring health-care costs, boosting support for Medicare for All https://pharmadog.xyz/news/609042 pharmadog en 2026-10-29T08:30:00.000Z Rising employer health premiums pressure workers as industry resists change https://pharmadog.xyz/news/609039 pharmadog en 2026-10-29T08:30:00.000Z AI as partner, competitor or crutch? Biologists weigh benefits and risks https://pharmadog.xyz/news/609040 pharmadog en 2026-10-29T08:30:00.000Z Treasury's Proposed China Investment Rule Sparks Debate Over Licensing Exemptions https://pharmadog.xyz/news/609138 pharmadog en 2026-10-29T05:11:00.000Z Ascletis oral GLP-1 candidate ASC30 meets primary and secondary goals in phase 2 diabetes study https://pharmadog.xyz/news/608240 pharmadog en 2026-10-29T04:01:00.000Z Biopharma manufacturing cuts slated to affect over 4,000 workers, with BioNTech leading layoffs https://pharmadog.xyz/news/608239 pharmadog en 2026-10-29T04:01:00.000Z Biopharma job postings in New York surge 109% year over year, eight firms hiring https://pharmadog.xyz/news/610382 pharmadog en 2026-10-29T04:00:00.000Z Medline orders removal of all brand beds and accessories over fire and asphyxiation hazards https://pharmadog.xyz/news/611133 pharmadog en 2026-10-29T00:00:00.000Z EMA and African regulator issue joint guidance to accelerate Ebola vaccine trials https://pharmadog.xyz/news/611134 pharmadog en 2026-10-29T00:00:00.000Z FDA approves Stada's Lucentis biosimilar; Lilly claims its triple-G candidate outperforms Ozempic in diabetes https://pharmadog.xyz/news/611638 pharmadog en 2026-10-29T00:00:00.000Z HHS issues interim policy allowing compounding of six unapproved peptides under set conditions https://pharmadog.xyz/news/611637 pharmadog en 2026-10-29T00:00:00.000Z FDA issues revised draft guidance for drug-device combination product performance